DERLADIE WITCH HAZEL PERFECT VITAMIN SERUM

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: DERLADIE WITCH HAZEL PERFECT VITAMIN SERUM
Generic name: NIACINAMIDE, ADENOSINE
Manufacturer: LAON COMMERCE co ltd
Product type: HUMAN OTC DRUG
SPL set ID: c7709e83-3246-d4f8-e053-2a95a90a2bbe
SPL ID: c7709df7-6ea5-6c59-e053-2995a90a032c
Version: 1
Effective date: 2021-07-18
Source export date: 2026-09-28
Source partition: 13
Source file: https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/e78bf8aa9f90ab13e640d254dfbd4fe5bfeca4995ec5f9d51bce3356e249cab7/drug-label-0013-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:31:57

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		DERLADIE WITCH HAZEL PERFECT VITAMIN SERUM	openfda.brand_name
generic name		NIACINAMIDE, ADENOSINE	openfda.generic_name
manufacturer name		LAON COMMERCE co ltd	openfda.manufacturer_name
ndc	package	82083-0002-1	openfda.package_ndc
ndc	product	82083-0002	openfda.product_ndc
ndc11	package	82083000201	derived:openfda.package_ndc
spl id		c7709df7-6ea5-6c59-e053-2995a90a032c	id
spl set id		c7709e83-3246-d4f8-e053-2a95a90a2bbe	set_id
unii		25X51I8RD4	openfda.unii
unii		K72T3FS567	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

■ if following abnormal symptoms persist, discontinue use Irritation around the eyes, ears, mucous membranes, including the mouth, under the skin irritation and rashes ■ Stop immediately and consult a doctor if you experience 1) Hypersensitivity symptoms such as erythema, itching and dermatitis. 2) Skin Irritation 3) Following Instructions when using medication (1) For external use only (Do not use internally) (2) Avoid getting into the eyes (if contact occurs, wash well with clean water)

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.